Thailand Medical News - For All The Latest Breaking Medical News, Health News, Research News, COVID-19 News, Outbreak News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Heart And Cardiology News, Epigenetic News, Cancer News,

BREAKING NEWS
COVID-19 Supplements - Vitamin K - Ferroptosis  Mar 18, 2023  11 months, 3 days, 6 hours, 9 minutes ago

COVID-19 Supplements: Exploring the Potential Role of Vitamin K in Suppressing SARS-CoV-2 Induced Ferroptosis

2617 Shares
facebook sharing button Share
twitter sharing button Tweet
linkedin sharing button Share
COVID-19 Supplements: Exploring the Potential Role of Vitamin K in Suppressing SARS-CoV-2 Induced Ferroptosis
COVID-19 Supplements - Vitamin K - Ferroptosis  Mar 18, 2023  11 months, 3 days, 6 hours, 9 minutes ago
COVID-19 Supplements: Researchers from the Department of Medical Biology and Biochemistry, Faculty of Medicine, Nicolaus Copernicus University in Toruń-Poland have conducted a study review examining the potential of Vitamin K in suppressing SARS-CoV-2 induced ferroptosis. Ferroptosis, a recently identified form of programmed cell death, is characterized by the accumulation of iron and lipid hydroperoxides within cells. Vitamin K is recognized for its antioxidant properties and its role in reducing oxidative stress, particularly in lipid cell membranes. By modulating the expression of antioxidant enzymes, Vitamin K reduces reactive oxygen species levels and diminishes inflammation, which may help prevent ferroptosis. SARS-CoV-2 infections, resulting in COVID-19, are linked to imbalances between oxidants and antioxidants. Research indicates that oxidative stress during SARS-CoV-2 infection can result in heightened ferroptosis occurring in various tissues and cells.


 
The study findings were published in the peer-reviewed journal: Antioxidants.
https://www.mdpi.com/2076-3921/12/3/733

Oxidative Stress, Lipid Peroxidation, and Antioxidant Defense Systems
Oxidant-antioxidant balance and lipid peroxidation involve the generation of reactive oxygen species (ROS) in cells as a consequence of oxygen consumption. ROS play a role in both cell damage and redox signaling. Lipid peroxidation (LPO) is a process responsible for oxidative stress and occurs in three stages: initiation, propagation, and termination. LPO products, including lipid hydroperoxides (LOOHs) and aldehydes, can damage proteins and DNA.
 
Cells have an antioxidant defense system to remove ROS, which includes enzymes like superoxide dismutase (SOD), glutathione peroxidase (GPx), catalase (CAT), and thioredoxin (Trx), as well as non-enzymatic antioxidants like vitamins, flavonoids, and minerals. Vitamin K also has antioxidant properties. The thioredoxin system and glutathione antioxidant system are the two main thiol-dependent antioxidant systems in mammals.
 
GPx plays a crucial role in removing hydrogen peroxide (H2O2) and LOOHs, with GPx4 being a key regulator of ferroptosis. By detoxifying hydroperoxides in membrane lipids, GPx4 reduces membrane damage and prevents the generation of reactive products from the peroxidation process.
 
Understanding Ferroptosis and Its Implications in Human Health
Ferroptosis is an iron-dependent form of regulated cell death that involves the oxidation of membrane lipids and is distinct from other types of cell death like apoptosis and necrosis. Phospholipids containing polyunsaturated fatty acids (PUFAs) play a significant role in ferroptosis. Oxidation of these lipids is connected to iron ions and iron-containing enzymes, such as lipoxygenases (LOXs).

Cellular iron availability is regulated by proteins like ferritin, which stores iron and prevents ferroptosis. The availability of iron in cells is also linked to compounds like glutathione (GSH), which forms a complex with iron and is involved in preventing lipid peroxidation (LPO) through glutathione peroxidase 4 (GPx4).

Endogenous antioxidants, such as coenzyme Q10 (CoQ10) and tetrahydrobiopterin (BH4), also suppress ferroptosis by inhibiting LPO. Ferroptosis has been implicated in various human health condi tions, including immune responses, cancer, and organ dysfunction in the brain, heart, liver, kidney, and lungs. It has been suggested that the regulatory mechanisms of ferroptosis, such as iron-mediated oxidative stress and the GPx4-GSH inhibition pathway, may be important for the treatment of COVID-19 and post-COVID-19 syndrome, as these conditions are strongly associated with mitochondrial dysfunction, iron overload, oxidative stress, and inflammation.
 
COVID-19 and Ferroptosis: A Complex Relationship
COVID-19 is associated with various complications, including dysregulation of iron homeostasis and iron overload, which could contribute to the disease's pathogenesis. Unregulated ferroptosis, a type of cell death caused by iron-dependent lipid peroxidation, may explain some of the lung damage seen in patients. The maintenance of iron balance is critical, as both low and high iron levels increase infection risk. COVID-19 patients often exhibit iron metabolism dysfunction.
 
The virus influences iron homeostasis by promoting hepcidin overexpression, which leads to increased iron accumulation in cells and the potential for ferroptosis. Inflammatory cytokines, such as IL-6, can also stimulate the synthesis of ferritin and hepcidin. Excessively high ferritin levels can lead to oxidative stress and worsen inflammation.

Ferroptosis can be both a defense mechanism against viral infections and a means for the virus to spread. SARS-CoV-2 appears to recruit enzymes like ACSL4 to generate reactive oxygen species and promote lipid peroxidation, ultimately leading to ferroptotic cell death and viral release. ACSL4 inhibitors have been found to significantly inhibit viral replication.
 
Inflammation, oxidative stress, and altered iron homeostasis are all involved in COVID-19 pathogenesis and progression. Ferroptosis in SARS-CoV-2 infection may lead to cognitive impairment, loss of taste and smell, and hypercoagulability. Additionally, ferroptosis has been implicated in heart injury, multiple organ failure, and potential brain damage in COVID-19 patients.
 
There is a link between ferroptosis and COVID-19, and understanding this process and its regulatory mechanisms has potential therapeutic significance. Inhibiting ferroptosis may offer reliable treatment methods for COVID-19. Some crucial regulatory targets of ferroptosis include system Xc− activity, the intracellular labile iron pool, GPx4 activity, GSH production, LPO, and phosphatidylethanolamine (PE) biosynthesis.
 
Potential therapeutic strategies include mediating GPx4 with selenium supplementation, using ACSL4 inhibitors like rosiglitazone and pioglitazone to decrease viral load, and enhancing the GPx4-GSH axis to lead to iron depletion. GSH supplementation, iron chelators, and lipophilic antioxidants, such as butylated hydroxytoluene or vitamin E, may also be beneficial adjunctive therapies in treating COVID-19.
 
Iron metabolism therapeutics could inhibit viral infection exacerbation caused by cell death. Anti-inflammatory cytokines and interfering with iron ion metabolism could be explored to improve patients' immunity.
 
Preliminary research suggests that vitamin K may be promising COVID-19 Supplements due to its antioxidant properties.
 
Vitamin K: A Potential Therapeutic Agent for COVID-19
Vitamin K refers to compounds derived from a synthetically obtained provitamin called menadione (K3). Vitamin K1 is found in plants and vegetable oils, while Vitamin K2 is found in meat, cheese, and fermented soybean products. Vitamin K plays a crucial role in blood coagulation, preventing osteoporosis, and reducing inflammation.
 
Vitamin K has a relationship with ferroptosis, a form of cell death. The reduced form of vitamin K inhibits lipid peroxidation and has antioxidant properties.
 
Vitamin K2 can also protect against cell death caused by oxidative stress, possibly through activation of the Nrf2 antioxidant pathway.
 
Given the potential role of ferroptosis in COVID-19 pathogenesis and the possible link between vitamin K and ferroptosis, there is interest in exploring the potential therapeutic benefits of vitamin K in COVID-19.
 
Vitamin K Supplementation in COVID-19: A Possible Approach
Vitamin K plays a role in protecting the lungs and has anti-inflammatory and antioxidant properties. Low vitamin K status is associated with higher mortality in COVID-19 patients, and vitamin K deficiencies have been observed in hospitalized adults with COVID-19 infection. Vitamin K derivatives are inversely correlated with levels of inflammatory cytokines and can increase the frequency of regulatory T cells, which maintain immune homeostasis.
 
Vitamin K deficiency is associated with factors that increase the risk of severe and fatal COVID-19, such as demographics, BMI, inflammatory markers, and comorbidities.
 
Future Directions and Conclusions
COVID-19 continues to be the subject of many medical studies. Imbalance in redox homeostasis and increased generation of ROS and RNS during infection can lead to severe COVID-19 outcomes. Vitamin K, a fat-soluble biomolecule, may offer therapeutic benefits by participating in coagulation and neutralizing ROS, potentially reducing ferroptosis and lipid peroxidation. Low vitamin K levels during COVID-19 are associated with higher mortality.
 
More research is needed to understand ferroptosis mechanisms and their role in COVID-19 progression and recovery. Exploring the antioxidant and immunomodulatory properties of vitamin K may prove valuable in treating SARS-CoV-2 infection. Further investigation can help establish a direct link between vitamin K status and ferroptosis, leading to the development of effective and safe therapies.
 
In conclusion, the study by Polish researchers highlights the potential therapeutic role of vitamin K in suppressing SARS-CoV-2 induced ferroptosis. While initial findings are promising, more extensive research is needed to confirm these results and develop appropriate treatment strategies for COVID-19. Understanding the complex relationship between ferroptosis, oxidative stress, inflammation, and iron homeostasis in COVID-19 pathogenesis may pave the way for novel therapeutic approaches and ultimately improve patient outcomes.
 
For the latest on COVID-19 Supplements, keep on logging to Thailand Medical News.

Read Also:
 
https://www.thailandmedical.news/news/researchers-in-netherlands-discover-that-lack-of-sufficient-vitamin-k-plays-a-role-in-covid-19-in-terms-of-lung-damage-and-thromboembolism
 
https://www.thailandmedical.news/news/university-of-bristol-study-shows-that-vitamins,-steroids-and-retinoids-can-help-as-adjuvants-to-treat-covid-19
 
https://www.thailandmedical.news/news/vitamin-k-new-study-shows-that-vitamin-k-may-offer-protective-health-benefits-in-the-elderly-especially-in-terms-of-vascular-health
 
https://www.thailandmedical.news/news/new-research-show-that-vitamin-k-reduces-risk-of-developing-type-ii-diabetes-by-51%-and-inhibits-metabolic-syndrome
 
https://www.thailandmedical.news/news/the-many-health-benefits-of-vitamin-k-supplements
 
https://www.thailandmedical.news/news/mobility-limitation-and-disability-in-the-aged-caused-by-low-vitamin-k-levels

 

MOST READ

Jun 10, 2023  9 months ago
COVID-19 News - DNA Methylation - Asymptomatic SARS-CoV-2 Infections
Sep 08, 2022  1 year ago
Source- Medical News - COVID-19 Research - Impaired Pain Modulation
Aug 04, 2022  2 years ago
Source: Medical News - SARS-CoV-2 & Cancer
Aug 13, 2020  4 years ago
Source: Supplements For COVID-19
Feb 05, 2020  4 years ago
Source : Thailand Medical news

FROM PHARMA NEWS

LATEST ON NURSING NEWS